Anti-snoring Devices and Snoring Surgery Market Size & Growth Forecast 2026–2035, By Segments (Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Anti-snoring Devices and Snoring Surgery Market size was estimated at USD 1.85 Billion in 2025 and is projected to grow at a 7.4% CAGR from 2026 to 2035, surpassing USD 3.78 Billion by 2035. The industry revenue for 2026 is calculated at USD 1.97 billion.

• Base Year Value (2025): USD 1.85 Billion
• CAGR (2026-2035): 7.4%
• Forecast Year Value (2035): USD 3.78 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Anti-snoring Devices and Snoring Surgery Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 39.86% market share in 2025, supported by established diagnosis pathways, higher patient awareness, and broad access to device-based and surgical treatments through specialized care.
  • Asia Pacific is forecast to grow at an 8.36% CAGR as improving sleep disorder diagnosis, greater treatment acceptance, and expanding clinical capacity accelerate adoption of devices and surgical interventions.

• Segment Momentum:

  • Oral Appliances/Mouthpieces accounted for 32.4% of the market in 2025 because they provide a practical, non-surgical solution that fits routine nightly use and offers a familiar approach to snoring management.
  • Position Control Devices are the fastest-growing segment as users increasingly prefer less intrusive, behavior-oriented solutions that address sleep-position-related snoring without oral insertion or surgical intervention.

• Market Expansion Drivers:

  • Rising obesity prevalence accelerating obstructive sleep apnea and chronic snoring cases.
  • Growth in minimally invasive snoring surgeries and advanced therapeutic device innovation.
  • Expansion of home sleep apnea testing and digital sleep monitoring for early diagnosis.

• Leading Market Participants:

  Top players in the anti-snoring devices and snoring surgery market include ResMed Inc. (United States), Koninklijke Philips N.V. (Netherlands), SomnoMed Limited (Australia), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Inspire Medical Systems Inc. (United States), Apnea Sciences Corporation (United States), Airway Management Inc. (United States), Sleep Well Enjoy Life Ltd. (United Kingdom), Tomed Dr. Toussaint GmbH (Germany), Braebon Medical Corporation (Canada).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 1.85 Billion
  • Projected Market Size: USD 3.78 Billion by 2035
  • Growth Forecasts: 7.4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Oral Appliances/Mouthpieces (Type)
  • Emerging Opportunity Segment: Position Control Devices (Type)

Market Growth Drivers and Industry Trends

Rising obesity prevalence accelerating obstructive sleep apnea and chronic snoring cases

As obesity becomes more prevalent, fat deposition around the neck and upper airway increases the likelihood of airway narrowing during sleep, raising the incidence of obstructive sleep apnea and persistent snoring. That clinical shift directly expands the addressable patient pool for the anti-snoring devices and snoring surgery market, particularly among adults moving from occasional snoring to medically significant sleep-disordered breathing. In practice, higher symptom severity pushes more patients toward treatment rather than self-management, strengthening demand for mandibular advancement devices, CPAP-adjacent snoring solutions, airway support products, and surgical intervention when anatomy-driven obstruction is harder to manage conservatively.

Growth in minimally invasive snoring surgeries and advanced therapeutic device innovation

Treatment adoption in the anti-snoring devices and snoring surgery market is being influenced by a clearer patient pathway between non-invasive therapy and traditional surgery, with minimally invasive procedures reducing the reluctance often associated with operative correction. Shorter recovery times, lower procedural burden, and better targeting of soft palate or airway obstruction make intervention more acceptable for patients whose symptoms persist despite device use. At the same time, innovation in therapeutic devices is improving comfort, fit, and usability, which matters in a category where adherence determines commercial success; manufacturers that solve tolerance and convenience issues are aiding market expansion by converting diagnosed patients into active long-term users.

Expansion of home sleep apnea testing and digital sleep monitoring for early diagnosis

The wider use of home sleep apnea testing and connected sleep monitoring is changing how patients enter the anti-snoring devices and snoring surgery market by making evaluation more accessible, less time-intensive, and easier to repeat. Earlier identification of snoring patterns, oxygen desaturation, and suspected apnea reduces dependence on hospital-based sleep studies alone, allowing more symptomatic individuals to move into formal diagnosis and treatment consideration. This trend supports market penetration by increasing physician confidence in triaging patients toward oral devices, monitored therapy, or surgical consultation, while digital tracking also helps sustain engagement by showing whether an intervention is improving nightly sleep outcomes.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising obesity prevalence accelerating obstructive sleep apnea and chronic snoring cases	2.20%	Low	North America, Europe	High	Near Term
Growth in minimally invasive snoring surgeries and advanced therapeutic device innovation	1.80%	High	North America, Asia Pacific	High	Mid Term
Expansion of home sleep apnea testing and digital sleep monitoring for early diagnosis	1.40%	Moderate	North America, Europe	Emerging	Near Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 39.86% share of the anti-snoring devices and snoring surgery market. This leadership is supported by established diagnosis and treatment pathways for sleep-related breathing disorders, wider patient awareness of snoring as a medical issue rather than only a lifestyle concern, and stronger availability of both device-based and surgical interventions through specialized care settings. In practice, the region benefits from a healthcare environment where patients are more likely to be evaluated, referred, and treated through structured clinical channels, which sustains procedure volumes and device adoption.

Asia Pacific is projected to expand at an 8.36% CAGR over the forecast period in the anti-snoring devices and snoring surgery market. Growth is being propelled by improving access to sleep disorder diagnosis, rising acceptance of treatment for snoring and related conditions, and broader availability of intervention options across developing healthcare systems. As clinical capacity expands and more patients enter formal treatment pathways, adoption is accelerating across both non-invasive devices and surgical solutions, reflecting a market that is moving from underdiagnosis toward more active management.

Key Country Insights

United States

Comprehensive Sleep Solutions

The U.S. anti-snoring devices and snoring surgery market is driven by growing awareness of sleep health and increasing demand for minimally invasive treatment options. Providers continue expanding personalized therapies that combine medical evaluation with device-based and surgical interventions.

Japan

Precision Therapy Adoption

Japan increasingly adopts advanced anti-snoring devices designed for patient comfort and consistent use. The market also supports targeted surgical interventions for appropriate cases, reflecting a preference for personalized sleep disorder management strategies.

South Korea

Minimally Invasive Preference

South Korea is witnessing broader adoption of minimally invasive anti-snoring procedures alongside innovative oral and wearable devices. Healthcare providers focus on improving treatment accessibility while delivering customized solutions that enhance patient compliance and satisfaction.

Germany

Clinical Treatment Integration

Germany emphasizes clinically validated anti-snoring devices and carefully selected surgical procedures within specialized sleep medicine practices. The market prioritizes treatment approaches that improve patient outcomes while supporting long-term management of sleep-related breathing disorders.

France

Specialist Sleep Care

France continues integrating anti-snoring therapies within specialized sleep clinics that combine diagnostic assessment with tailored treatment selection. The market values clinically supported devices and surgical options that address patient-specific anatomical and functional needs.

Italy

Patient-Centered Treatment

Italy's anti-snoring devices and snoring surgery market is evolving through greater awareness of sleep disorders and broader access to specialist care. Providers increasingly recommend individualized combinations of device-based therapies and surgical procedures based on clinical evaluation and patient preferences.

Segment Leadership and Growth Trends

  Type Segment Analysis: Oral Appliances/Mouthpieces (Largest Segment) vs Position Control Devices (Fastest-Growing Segment)

Within the anti-snoring devices and snoring surgery market, Oral Appliances/Mouthpieces held a 32.4% share in 2025, making this the leading type segment. Its position is sustained by practical day-to-day usability: these devices are widely adopted because they offer a non-surgical approach that fits routine nighttime use and addresses snoring through a straightforward mechanical method. That combination of accessibility and familiarity helps Oral Appliances/Mouthpieces maintain leadership in the anti-snoring devices and snoring surgery market, particularly among users seeking a manageable option before considering more involved interventions.

Position Control Devices are emerging as the fastest-growing type in the anti-snoring devices and snoring surgery market as demand shifts toward solutions that target sleep-position-related snoring in a more behavior-oriented way. Their momentum is being underpinned by growing user interest in less intrusive management approaches that can work without oral insertion or surgery, which gives them a clear advantage relative to more conventional alternatives for certain patient needs. As a result, Position Control Devices are seeing wider adoption where comfort preferences and practical adherence increasingly shape device selection in the anti-snoring devices and snoring surgery market.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps, Tongue Stabilizing Devices, EPAP Therapy Devices	Oral Appliances/Mouthpieces	Position Control Devices

Competitive Landscape and Market Positioning

Major players in the anti-snoring devices and snoring surgery market:

1. ResMed Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. SomnoMed Limited (Australia)

4. Fisher & Paykel Healthcare Corporation Limited (New Zealand)

5. Inspire Medical Systems Inc. (United States)

6. Apnea Sciences Corporation (United States)

7. Airway Management Inc. (United States)

8. Sleep Well Enjoy Life Ltd. (United Kingdom)

9. Tomed Dr. Toussaint GmbH (Germany)

10. Braebon Medical Corporation (Canada)

The anti-snoring devices and snoring surgery market is progressing through continuous innovation in wearable sleep technologies and minimally invasive treatment solutions. Rising consumer awareness regarding sleep health, combined with advancements in comfort-focused device design, is encouraging broader adoption and strengthening product competitiveness.

Industry Development/News

Company Name	Date	Key Development
Illusion Aligners	Jun-22	Illusion Aligners introduced a lightweight oral anti-snoring device designed to alleviate obstructive sleep apnea (OSA) symptoms. By focusing on usability and patient comfort, the product aims to address market demand for non-invasive sleep aids that improve sleep quality and reduce daytime fatigue, expanding the company’s footprint in respiratory wellness.
Signifier Medical Technologies	Feb-21	Signifier Medical Technologies received FDA marketing clearance for a device indicated for the reduction of mild obstructive sleep apnea and snoring in adults. This regulatory achievement enables the company to commercialize its non-invasive intervention technology, providing a clinical alternative to traditional snoring surgeries and continuous airway pressure devices.